Facing increasing revenue pressures, the state expects to save $17 million per year from the move
Expanded Therapeutic Applications of GLP-1 Medications 1
A doctor and a patient working together to adjust the dosage of a medication is not a new practice, but microdosing GLP-1 medications is a different animal
You can book a weight loss visit with a licensed doctor at DrHouse, and the doctor makes the final call on whether a GLP-1 is safe and appropriate for you
In the United States, prescribing information for all medications licensed for obesity that act on the CNS, including the GLP-1RAs liraglutide 3 mg (Saxenda) and semaglutide 2.4 mg (Wegovy), must include the recommendation of monitoring for depression and suicidal ideation 231
GLP-1 receptor agonists are typically prescribed for individuals who are struggling with obesity or overweight, particularly when traditional weight loss methods have proven insufficient